BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20087582)

  • 1. Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.
    Dong B; Sun L; Wu X; Zhang P; Wang L; Wei H; Zhou L; Hu X; Yu Y; Hua S; Wang L
    Cancer Immunol Immunother; 2010 Jun; 59(6):899-908. PubMed ID: 20087582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice.
    Dong B; Dai G; Ding Y; Wang B; Zhang S
    Int Immunopharmacol; 2018 Feb; 55():306-311. PubMed ID: 29310106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of MHSP65-TCL anti-melanoma vaccine on the activity of immunocytes].
    Dong B; Dai G; Qi Z; Yang G; Lu J; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1673-7. PubMed ID: 24273276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of mHSP65-TTL enhanced by administration of low dose cyclophosphamide in pancreatic cancer-bearing mice.
    Xuan W; Yan Y; Wan M; Wu X; Ji D; Wang L; Lin C; Chen Y; Yu Y; Zhang X
    Int Immunopharmacol; 2015 Jul; 27(1):95-103. PubMed ID: 25907246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice.
    Yang M; Yan Y; Fang M; Wan M; Wu X; Zhang X; Zhao T; Wei H; Song D; Wang L; Yu Y
    Int Immunopharmacol; 2012 Aug; 13(4):408-16. PubMed ID: 22595192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model.
    Kraśko JA; Žilionytė K; Darinskas A; Strioga M; Rjabceva S; Zalutsky I; Derevyanko M; Kulchitsky V; Lubitz W; Kudela P; Miseikyte-Kaubriene E; Karaman O; Didenko H; Potebnya H; Chekhun V; Pašukonienė V
    Oncol Rep; 2017 Jan; 37(1):171-178. PubMed ID: 27878261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of in vivo anti-tumor activity of human umbilical vein endothelial cell vaccines prepared by various antigen forms.
    Zhou L; Si C; Li D; Lu M; Zhong W; Xie Z; Guo L; Zhang S; Xu M
    Eur J Pharm Sci; 2018 Mar; 114():228-237. PubMed ID: 29277666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice.
    Dong B; Wang L; Nie S; Li X; Xiao Y; Yang L; Meng X; Zhao P; Cui C; Tu L; Lu W; Sun W; Yu Y
    Vaccine; 2018 Dec; 36(52):8148-8157. PubMed ID: 30449633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with B16 tumor cell lysate plus recombinant Mycobacterium tuberculosis Hsp70 induces antimelanoma effect in mice.
    Li H; Yu Y; Sun L; Wang H; Zhang P; Wei H; Wang L; Wan M; Cao Z; Wang Y; Chen Y; Dong B; Wang L
    Cancer Biother Radiopharm; 2010 Apr; 25(2):185-91. PubMed ID: 20423232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum chaperone glucose regulated protein 170-Pokemon complexes elicit a robust antitumor immune response in vivo.
    Yuan B; Xian R; Wu X; Jing J; Chen K; Liu G; Zhou Z
    Immunobiology; 2012 Jul; 217(7):738-42. PubMed ID: 22317751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
    Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
    Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J; Wang CL; Hao XS
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial HSP70 peptide epitope 407-426 as adjuvant in tumor-derived autophagosome vaccine therapy of mouse lung cancer.
    Li J; Xing Y; Zhou Z; Yao W; Cao R; Li T; Xu M; Wu J
    Tumour Biol; 2016 Nov; 37(11):15097-15105. PubMed ID: 27662838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yankai Z; Rong Y; Yi H; Wentao L; Rongyue C; Ming Y; Taiming L; Jingjing L; Jie W
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1365-71. PubMed ID: 16725110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis.
    Kumar Chauhan S; Kumar Tripathy N; Sinha N; Singh M; Nityanand S
    Clin Exp Immunol; 2004 Dec; 138(3):547-53. PubMed ID: 15544635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models.
    Wang ZY; Xing Y; Liu B; Lu L; Huang X; Ge CY; Yao WJ; Xu ML; Gao ZQ; Cao RY; Wu J; Li TM; Liu JJ
    Chin J Cancer; 2012 Jun; 31(6):295-305. PubMed ID: 22464650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
    Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J
    J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.